MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- Indian - mnc pharma
- PFIZER - TTK HEALTHCARE
PFIZER vs TTK HEALTHCARE - Comparison Results
Current Valuations
| PFIZER | TTK HEALTHCARE | PFIZER/ TTK HEALTHCARE |
|||
|---|---|---|---|---|---|
| P/E (TTM) | x | 37.4 | 22.3 | 168.2% | View Chart |
| P/BV | x | 6.4 | 1.5 | 429.6% | View Chart |
| Dividend Yield | % | 0.5 | 1.0 | 51.5% |
Financials
 PFIZER  TTK HEALTHCARE |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| PFIZER Mar-19 |
TTK HEALTHCARE Mar-19 |
PFIZER/ TTK HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 3,840 | 1,215 | 316.0% | |
| Low | Rs | 2,080 | 610 | 340.9% | |
| Sales per share (Unadj.) | Rs | 455.0 | 444.4 | 102.4% | |
| Earnings per share (Unadj.) | Rs | 93.8 | 17.2 | 543.8% | |
| Cash flow per share (Unadj.) | Rs | 109.4 | 27.6 | 395.9% | |
| Dividends per share (Unadj.) | Rs | 22.50 | 5.00 | 450.0% | |
| Dividend yield (eoy) | % | 0.8 | 0.5 | 138.7% | |
| Book value per share (Unadj.) | Rs | 658.2 | 177.9 | 369.9% | |
| Shares outstanding (eoy) | m | 45.75 | 14.13 | 323.8% | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 6.5 | 2.1 | 316.8% | |
| Avg P/E ratio | x | 31.6 | 52.9 | 59.7% | |
| P/CF ratio (eoy) | x | 27.1 | 33.0 | 81.9% | |
| Price / Book Value ratio | x | 4.5 | 5.1 | 87.7% | |
| Dividend payout | % | 24.0 | 29.0 | 82.8% | |
| Avg Mkt Cap | Rs m | 135,420 | 12,894 | 1,050.2% | |
| No. of employees | `000 | 2.6 | 2.3 | 113.8% | |
| Total wages/salary | Rs m | 3,238 | 1,307 | 247.8% | |
| Avg. sales/employee | Rs Th | 7,911.4 | 2,715.7 | 291.3% | |
| Avg. wages/employee | Rs Th | 1,230.9 | 565.3 | 217.7% | |
| Avg. net profit/employee | Rs Th | 1,630.7 | 105.4 | 1,547.1% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 20,815 | 6,279 | 331.5% | |
| Other income | Rs m | 1,674 | 78 | 2,159.9% | |
| Total revenues | Rs m | 22,489 | 6,356 | 353.8% | |
| Gross profit | Rs m | 5,712 | 496 | 1,152.5% | |
| Depreciation | Rs m | 714 | 147 | 486.6% | |
| Interest | Rs m | 73 | 34 | 215.7% | |
| Profit before tax | Rs m | 6,599 | 393 | 1,680.9% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 2,309 | 149 | 1,550.4% | |
| Profit after tax | Rs m | 4,291 | 244 | 1,760.6% | |
| Gross profit margin | % | 27.4 | 7.9 | 347.7% | |
| Effective tax rate | % | 35.0 | 37.9 | 92.2% | |
| Net profit margin | % | 20.6 | 3.9 | 531.1% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 27,167 | 2,717 | 999.8% | |
| Current liabilities | Rs m | 8,917 | 1,571 | 567.7% | |
| Net working cap to sales | % | 87.7 | 18.3 | 480.2% | |
| Current ratio | x | 3.0 | 1.7 | 176.1% | |
| Inventory Days | Days | 68 | 32 | 210.9% | |
| Debtors Days | Days | 30 | 47 | 64.5% | |
| Net fixed assets | Rs m | 8,862 | 991 | 894.2% | |
| Share capital | Rs m | 458 | 141 | 323.8% | |
| "Free" reserves | Rs m | 29,656 | 2,373 | 1,249.7% | |
| Net worth | Rs m | 30,113 | 2,514 | 1,197.7% | |
| Long term debt | Rs m | 25 | 3 | 735.3% | |
| Total assets | Rs m | 39,400 | 4,158 | 947.5% | |
| Interest coverage | x | 91.5 | 12.6 | 725.5% | |
| Debt to equity ratio | x | 0 | 0 | 61.4% | |
| Sales to assets ratio | x | 0.5 | 1.5 | 35.0% | |
| Return on assets | % | 11.1 | 6.7 | 165.9% | |
| Return on equity | % | 14.2 | 9.7 | 147.0% | |
| Return on capital | % | 22.1 | 16.9 | 130.7% | |
| Exports to sales | % | 0 | 3.6 | 0.0% | |
| Imports to sales | % | 0 | 0.5 | 0.0% | |
| Exports (fob) | Rs m | NA | 225 | 0.0% | |
| Imports (cif) | Rs m | NA | 31 | 0.0% | |
| Fx inflow | Rs m | 428 | 225 | 190.2% | |
| Fx outflow | Rs m | 786 | 71 | 1,105.9% | |
| Net fx | Rs m | -358 | 154 | -232.4% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 978 | 173 | 565.0% | |
| From Investments | Rs m | 351 | 97 | 363.9% | |
| From Financial Activity | Rs m | -1,099 | -307 | 357.5% | |
| Net Cashflow | Rs m | 231 | -38 | -612.2% | |
Share Holding
| Indian Promoters | % | 0.0 | 65.4 | - | |
| Foreign collaborators | % | 63.9 | 0.0 | - | |
| Indian inst/Mut Fund | % | 7.5 | 3.7 | 202.7% | |
| FIIs | % | 4.9 | 5.2 | 94.2% | |
| ADR/GDR | % | 0.0 | 0.0 | - | |
| Free float | % | 23.7 | 25.8 | 91.9% | |
| Shareholders | 85,207 | 12,723 | 669.7% | ||
| Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PFIZER With: ALEMBIC LTD SUN PHARMA PIRAMAL ENTERPRISES GLENMARK PHARMA SHASUN PHARMA
Compare PFIZER With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US) TEVA PHARMA (Israel)
Today's Market
Sensex Ends 428 Points Higher; Energy and Healthcare Stocks Witness Buying(Closing)
Indian share markets continued their momentum during closing hours and ended their trading session on a positive note today.
Related Views on News
PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)
Feb 19, 2020 | Updated on Feb 19, 2020For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.
TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)
Jan 30, 2020 | Updated on Jan 30, 2020For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)
Oct 29, 2019 | Updated on Oct 29, 2019For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.
PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)
Aug 13, 2019 | Updated on Aug 13, 2019For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.
TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)
Aug 13, 2019 | Updated on Aug 13, 2019For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
More Views on NewsMost Popular
This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)
Feb 11, 2020A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.
How to Become a One Stock Crorepati(Profit Hunter)
Feb 6, 2020A little known Indian stock that is set to turn around its own fortunes, and your wealth, if you just have the foresight to get in on time...
Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)
Feb 11, 2020How to fight back against algo trading systems.
Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)
Feb 14, 2020This proven strategy can give big returns in quick time.
No Change in My Long-Term View on the Rebirth of India Stocks(The 5 Minute Wrapup)
Feb 6, 2020Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.
MoreOUR TOP 5 IDEAS
- Free Guide on How to Profit from Sensex 100,000.
- 7 Stocks to Ride the Coming Rebirth of India Rally. Full Details Here...
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Revealed: Top 7 Stocks to Consider Buying Right Now...
PFIZER SHARE PRICE
Feb 19, 2020 (Close)
TRACK PFIZER
- Track your investment in PFIZER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON PFIZER
PFIZER 8-QTR ANALYSIS
COMPARE PFIZER WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.